screening and immunotyping monoclonal antibody using the...

42
Screening and Immunotyping Monoclonal Antibody using the V8 Nexus Ankara July 2019 Tony Aitchison Helena Biosciences

Upload: others

Post on 30-Apr-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Screening and Immunotyping

Monoclonal Antibody using the

V8 Nexus

Ankara – July 2019

Tony Aitchison – Helena Biosciences

Page 2: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Multiple Myeloma

• Cancerous plasma cell tumour mass

• Clonal expansion of Plasma & B Cells

• Monoclonal antibody production

• Serum monoclonal antibody level

indirectly proportional to tumour mass

• Serum Protein Electrophoresis

Page 3: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Serum Protein Screening using Helena

Helena platform can address

entire serum protein screening

requirements:

• High throughput CZE screening

• Sensitive immunotyping

• Powerful integration

• Comprehensive training

Page 4: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

V8 Nexus

• Capillary electrophoresis

• 8 Channel

• Full walk away automation

• Multi test analyser

• Automated maintenance

• Gel integration

• Track and network integration

Page 5: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

SAS Gel Electrophoresis

• Semi automated

• SAS-3 Electrophoresis

• SAS-4 Stainer

• Automated sample prep

using V8 Nexus

• Common database for Gel

and CZE results

Page 6: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Serum Protein Screening

• CZE separation on the V8

• Split beta separation

• High throughput

• Accurate monoclonal measurement

• Easily compare to historic results

Page 7: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Capillary Electrophoresis

• Sample cups loaded at anode

• Vacuum applied to load capillary

• Current applied to facilitate

separation

• Absorbance measured as

protein passes the detector

Page 8: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Electro-Osmotic Flow (EOF)

• Silica capillaries have

negative charge

• Run buffer coats capillary

neutralising charge

• Remaining buffer flows

through capillary

Page 9: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Sample Stacking

• Differences in protein mobility

between diluent and buffer

stack protein prior to separation

• Diluent – fast mobility

• Run buffer – slow mobility

Page 10: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Serum Protein Electropherogram

Pre-Albumin

Albumin

Alpha-1-acid Glycoprotein

Alpha-1-antitrypsin

Haptoglobin

Alpha-2-macroglobulin

Haemopexin

Transferrin

Complement

CRP

Immunoglobulin

Page 11: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Six Band Serum Protein Trace

Albumin

Alpha-1

Alpha-2

Beta-1

Beta-2

GammaGamma

Page 12: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Additional Peak

100 200

(sec)

0

50

100

Page 13: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Additional Peak

100 200

(sec)

0

50

100

Gamma M-spike 1

Page 14: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Relative Peak Percentages

0 20 40

(sec)

0

50

100

Page 15: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Relative Peak Percentages

0 20 40

(sec)

0

50

100

Beta-2 M-spike 1

Page 16: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunoglobulin Migration – Heavy Chains

IgMIgGIgA

Page 17: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunoglobulin Migration – Light Chains

Kappa

Lambda

Page 18: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Monoclonal Migration – Relative Incidence

HighLow

Page 19: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Polyclonal Response

IgG Polyclonal Response

Normal

Page 20: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Polyclonal Response – Clone Specific

IgMIgGIgA

Page 21: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Polyclonal Response – IgG and IgA Response

Page 22: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunotyping Monoclonal Antibody

• Confirm the presence of monoclonal

• Immunotype monoclonal

• Two methodologies

• CZE immunodisplacement

• Gel immunofixation

• Both have pros and cons

Page 23: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunodisplacement Antisera

-

• One antisera for each major chain

• IgG, IgA, IgM, Kappa & Lambda

• Chemically treated to add strong

negative charge to antibody

• Reduces electrophoretic mobility

Page 24: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunodisplacement

• Antisera added to sample

• Antisera will bind all

immunoglobulin of a specific

immunotype

– Monoclonal

– Polyclonal

Page 25: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Reduced Mobility

• Antisera bound

immunoglobulin migrates

significantly slower than

unbound immunoglobulin

• Immunoglobulin removed

from trace

Page 26: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunodisplacement – IgM Monoclonal

Page 27: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunodisplacement – IgM Monoclonal

Page 28: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunodisplacement

Immunodisplacement Serum Protein Screen

• Five antisera required

– IgG, IgA, IgM

– Kappa & Lambda

• Five capillaries

• Linked to original

screening trace

Page 29: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunodisplacement

Immunodisplacement

Serum Protein Screen

Page 30: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunodisplacement Overlay

IgG IgA IgM

Kappa Lambda

IgG IgA IgMIgG IgA

Kappa

IgMIgG IgA

LambdaKappa

IgMIgG IgA

LambdaKappa

IgM

LambdaKappa

IgA IgM

LambdaKappa

IgG IgA IgM

LambdaKappa

Page 31: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

IgM Kappa Monoclonal

IgG IgA IgM

Kappa Lambda

Page 32: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Polyclonal Removal

IgG IgA IgM

Kappa Lambda

Page 33: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Example Case Study

100 200

(sec)

0.00

0.01

0.02

0.03

• Serum protein

screening trace

Page 34: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Example Case Study

100 200

(sec)

0.00

0.01

0.02

0.03

Beta-2 M-spike 1

Gamma M-spike 1

• Two monoclonal

peaks

• Beta-2 monoclonal

• Gamma Monoclonal

Page 35: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Example Case Study - Immunodisplacement

• Two monoclonal

peaks

• Beta-2 monoclonal

• Gamma Monoclonal

IgG

IgA IgM

LambdaKappa

IgG

IgA IgM

IgG

IgA

Lambda

IgM

IgG

IgA

Kappa Lambda

IgM

IgG

IgA

Page 36: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Example Case Study - Immunodisplacement

• Two monoclonal

peaks

• IgA Kappa x2

Kappa Lambda

IgM

IgG

IgA

Page 37: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunotyping

How to choose between methods

• Immunodisplacement

• Medium & large peaks

• Suspected co migrating peaks

• Fast / automated

• Immunofixation

• Small peaks

• Manual

• Batches

Immunodisplacement

Immunofixation

Page 38: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Immunofixation

• Customise for purpose

• Screening versus / typing

• Suggested dilution schemes

• Screening

• 52233

• Immunotyping

•Monoclonal specific

Page 39: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

IFE Dilution Scheme

Total Immunoglobulin Chain Vs Monoclonal Sensitivity

0

10

20

30

40

50

60

70

0.06 0.12 0.18 0.24 0.3 0.36 0.42 0.48 0.54 0.6 0.66 0.72 0.78 0.84 0.9 0.96 1.02 1.08 1.14 1.2

Monoclonal sensitivity (g/L)

To

tal im

mu

no

glo

bu

lin

ch

ain

(g

/L)

Prozoning

Resolution

Page 40: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

IFE Dilutions

Page 41: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

IFE Dilutions

Page 42: Screening and Immunotyping Monoclonal Antibody using the ...portal.citius.technology/images/48/Dosyalar/tmp/Serum Protein Scre… · Multiple Myeloma • Cancerous plasma cell tumour

Any Questions

Ankara – July 2019

Tony Aitchison – Helena Biosciences